Our team has "Done it Before" is "Dependable" and will "Delivery Confidently", the 3 D's essential for successful Execution. At PAR Clinical we can build an ecosystem to support your functional needs and help advance your drug development vision forward. To learn more please reach out to us at - [email protected] or visit us at www.parclinical.com
PAR Clinical
生物技术研究
Woburn，Massachusetts 1,023 位关注者
A Strategic Knowledge Research Organization, building ecosystems to advance drug development using our SPEO Model.
关于我们
PAR Clinical was founded as a “Strategic life sciences consulting firm” with a focus on developing strategies for the healthcare industry to help improve patient lives. As a strategic life science consulting firm, we are structured to deliver a tailored operational solution to our clients to help them achieve successful organizational outcomes. Our tailored business solution is structured around two unique service models: 1)Strategic Consulting Model (Plug and Play Model): In this model, we act as an extension of your team to provide functional expertise within your organization: a)Functional Expertise: Start-ups require strong functional expertise and infrastructure to design and execute their clinical strategies. Support mission-critical challenges or problems that require a set of expertise which is missing at the inception phase of a company. PAR Clinical supports newly formed Biotech firms with expertise where they lack the muscle memory or in-house expertise to confidently execute their projects. b)Objective Analysis/Opinion: Our strategic consulting team can assist with objective analysis and decision making in scenarios where your drug development strategy requires a third-party opinion. PAR Clinical as a consulting firm can bring in an objective view on industry best practices, essentially leveraging their wider purview of how other companies have tackled similar problems. c)On-Demand Brains: Since start-up companies are too small they require an injection of smart people and "brains" to bring to bear the problem at hand. With PAR Clinical, infrastructure is already in place and since our teams have been working together as a unit for several years catering to different client needs it is a quick and seamless integration within your organization to focus on true challenges. 2) Contract Research Organization: Run your clinical trials/studies as boots on the ground with expertise in Regulatory, Clinical Operations and Biometrics.
- 网站
-
www.parclinical.com
PAR Clinical的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Woburn，Massachusetts
- 类型
- 个体经营
- 创立
- 2022
- 领域
- Strategic Consulting, Clinical Development, Contract Research Organization,
地点
-
主要
获取路线
Baldwin Green Common
US，Massachusetts，Woburn，01801
PAR Clinical员工
动态
-
Since its inception, as a "Knowledge Research Organization," KRO our goal at PAR Clinical has been to build ecosystems that provide strategic and operational expertise to clinical-stage drug development companies. We continue to support multiple clients in their drug development journey and strongly believe in the mantra "Your Success is Our Success" We would appreciate an opportunity to add value to your drug development journey. #KRO, #CROs, #Biotechconsulting #Biotechnology #Pharmaceuticals #Bio
-
-
Clinical Operations and Oversight: A critical element of your clinical development team is your clinical operations team. As a Knowledge Research Organization (KRO), we provide strategic perspectives, plan your clinical studies, and execute them using our trademark model SPEO, reducing dependency on CROs. Please reach out to us to learn more: [email protected]
-
-
Wishing everyone a Happy New Year!! We look forward to an exciting 2025 as we continue to grow into a Knowledge Research Organization (KRO), implementing our trademark "SPEO" Model to offer our clients a "Robust Platform" to de-risk their clinical development strategies. Schedule a call to learn more about how we have helped our clients de-risk their programs over the last few years and how the "SPEO" Model may be the right fit to support your clinical development needs.
-
-
As we reflect on 2024, despite multiple challenges due to the changing landscape within the Pharmaceutical and Biotechnology industry we have grown organically. This year, we have made numerous strides toward building a strong foundation as we prepare for a much anticipated positive shift in the biotech funding scenario in 2025. Check out this holiday message from our CEO and Founder Siddharth Parulkar
-
We are excited to welcome Faizzan Ahmad, PhD(Oxon) onboard PAR Clinical as our Strategic Advisory Board (SAB) member. A recognized thought leader in regenerative medicine, Dr. Ahmad is equally passionate about fostering global innovation ecosystems like PAR Clinical. We are thrilled to have his strategic expertise, background in biotech finance, and pioneering insights to advance our mission of building ecosystems for drug development companies.
-
-
As we gear up for the Thanksgiving holiday, I am sure we are all grateful for the things in our lives and opportunities that have come our way this year. At PAR Clinical we are grateful for the opportunities that have come our way and would like to thank our clients, colleagues, collaborates, and families for your support.
-
-
We are delighted to welcome @LydiaJoh, Ph.D onboard the PAR Clinical team as a Clinical Operations Manager. With a Ph.D in Molecular and Cell Biology and over 5 years of experience in genetics, protein and cell culture work she brings in a blend of operational experience from laboratory to clinical settings.?
-
-
An article from our CEO on how mimicking the Hollywood model maybe another way to develop drugs through resource and cost optimization. This is exactly where PAR Clinical is positioned to help you in your drug development journey!!
CEO and Founder at PAR Clinical I Building Ecosystems to advance drug development I Podcaster: Framing The Foundation Podcast
Just released: Check out my article published in Clinical Leader: "Mimicking The Hollywood Mindset To Develop Drugs In An Era Driven By Capital Markets" I want to thank Vishal Mehta, CEO and founder of Ubuntu Research Inc, for introducing me to Pisano and Lo's works regarding a project-focused approach. PAR Clinical had implemented the SPEO model before knowing this research existed but it was encouraging to see academia thinking along similar lines. Love to get your feedback.